528
Participants
Start Date
June 30, 2015
Primary Completion Date
October 31, 2022
Study Completion Date
October 31, 2022
cisplatin and paclitaxel
"1. Paclitaxel, 175mg/m2, d1, Cisplatin, 25mg/m2, d2-d4, 3 week, 2 cycles.~2. Paclitaxel, 87.5mg/m2, d1,d8, Cisplatin, 25mg/m2, d2-d4, 3 week, 2 cycles.~3. Paclitaxel, 175mg/m2, d1, Cisplatin, 75mg/m2, d1, 3 week, 2 cycles."
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing
Beijing Cancer Hospital, Beijing
Tianjin Medical University Cancer Institute and Hospital, Tianjin
Hunan Province Tumor Hospital, Changsha
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university, Zhengzhou
Sun Yat-sen Uniersity Cancer Center, Guangzhou
Fujian Medical University Union Hospital, Fuzhou
Anyang cancer hospital, Anyang
Fudan Universitay Shanghai Cancer Center, Shanghai
Tianjin Medical University Cancer Institute and Hospital
OTHER
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OTHER
Peking University Cancer Hospital & Institute
OTHER
Hunan Province Tumor Hospital
OTHER
Sun Yat-sen University
OTHER
Henan Cancer Hospital
OTHER_GOV